Back to search results
NCT07221578

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

Active, Not Recruiting
PHASE3Ages 18–65InterventionalTreatment
Vanda Pharmaceuticals
~500 participants
Updated 2026-08-17 on ClinicalTrials.gov
What's tested:VQW-765Placebo

At a glance

Recruiting sites
0 of 30 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Subjective Units of Distress Scale (SUDS)
Measured over 1 day

Conditions

Social Anxiety Disorder (SAD)

Explore related trials

Social Anxiety Disorder

NCT07221578

Where you'd take part

This study runs at 30 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Vanda Investigational Site

    Phoenix, Arizonano site contact published

  • Vanda Investigational Site

    Scottsdale, Arizonano site contact published

  • Vanda Investigational Site

    Encino, Californiano site contact published

  • Vanda Investigational Site

    Mission Viejo, Californiano site contact published

  • Vanda Investigational Site

    San Diego, Californiano site contact published

  • Vanda Investigational Site

    San Jose, Californiano site contact published

  • Vanda Investigational Site

    Walnut Creek, Californiano site contact published

  • Vanda Investigational Site

    Denver, Coloradono site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Subjective Units of Distress Scale (SUDS)1 day

    Subjective Units of Distress Scale (SUDS) during performance phase, scored from 0-100 with a higher score indicating higher distress.